Mid
A
ANABAI Stock Diagnostic Report
AnaptysBio quickly drops amid hearing on GSK/Tesaro contract breach
NaptisBio's stock price dropped 8% ahead of the contract violation hearings with GSK and Tesaro.
View Source Article ↗AI CATALYST SCORE45 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time